⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL364115 | 0.76 | — | — | |
| SCHEMBL12311378 | 0.76 | — | — | |
| SCHEMBL28942073 | 0.76 | — | — | |
| SCHEMBL12311377 | 0.76 | — | — | |
| SCHEMBL24848507 | 0.74 | CA12 (0.42) | — | |
| SCHEMBL17374387 | 0.74 | — | — | |
| SCHEMBL2122233 | 0.74 | CA12 (0.42) | — | |
| SCHEMBL19523013 | 0.74 | — | — | |
| SCHEMBL18885420 | 0.74 | CA12 (0.42) | — | |
| SCHEMBL4431109 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7745459-B2 | Quinolizinone compound and use thereof as HIV integrase inhibitor | JAPAN TOBACCO INC. (JP) | 2010-06-29 | — | — | US | disclosed |
| US-20060084665-A1 | Quinolizinone compound and use thereof as HIV integrase inhibitor | JAPAN TOBACCO INC. (JP) | 2006-04-20 | — | — | US | disclosed |